Psychedelics Today, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

PT432 – From NBA Dreams to Cultural Healing: Iboga and a...

FILAMENT HEALTH AND NASDAQ-LISTED SPAC JUPITER ACQUISITION CORP. ANNOUNCE FILING OF...

Clearmind Medicine Announces Collaboration with CTS Ltd., a Leading Pharmaceutical and...

Psychedelic Bulletin #143: Trademark Filing Reveals Potential Brand Name for MDMA;...

PT431 – The Concept of Integration and the Need for Evolving...

Apex Labs announces the appointment of Chief Medical Officer & Chief...

Optimi Health Announces CAD $3,000,000 Senior Debt Financing

Silo Pharma Engages Clarivate for Intellectual Property and Patent Management

atai Life Sciences Reports Second Quarter 2023 Financial Results and Operational...

Exploring the Vast Potential of Psychedelic Medicine: A Physician’s Perspective on...

1...505152...218 Page 51 of 218

EDITOR PICKS

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin